While APOE4 and the PRSs were both associated to clinical AD diagnosis, only APOE4 was associated to P-tau181 levels in blood years before diagnosis, further supporting the theory that APOE4 has a crucial etiological role in amyloid deposition and other genetic risk loci may support further pathological processes in disease progression. The gene discussed is APOE; the disease is Alzheimer disease.